Literature DB >> 11154691

Stimulation of NF-E2 DNA binding by CREB-binding protein (CBP)-mediated acetylation.

H L Hung1, A Y Kim, W Hong, C Rakowski, G A Blobel.   

Abstract

The hematopoietic transcription factor NF-E2 is an important regulator of erythroid and megakaryocytic gene expression. The transcription cofactor cAMP-response element-binding protein (CREB)-binding protein (CBP) has previously been implicated in mediating NF-E2 function. In this report, we examined the role of CBP, a coactivator with intrinsic acetyltransferase activity, in the regulation of NF-E2. We found that both the hematopoietic-specific subunit of NF-E2, p45, and the widely expressed small subunit, MafG, interact with CBP in vitro and in vivo. CBP acetylates MafG, but not p45, predominantly in the basic region of MafG. Immunoprecipitation experiments with anti-acetyl lysine antibodies demonstrate that MafG is acetylated in vivo in erythroid cells. Transfection experiments further show that CBP stimulates MafG acetylation in intact cells in an E1A-sensitive manner. Acetylation of MafG augments DNA binding activity of NF-E2, and mutations at the major acetylation sites markedly reduce DNA binding and transcriptional activation by NF-E2. Together, these results suggest that recruitment of CBP by NF-E2 to specific erythroid/megakaryocytic promoters might regulate transcription by at least two mechanisms involving both modification of chromatin structure and modulation of transcription factor activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11154691     DOI: 10.1074/jbc.M007846200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Characterization of the human beta-globin downstream promoter region.

Authors:  Kelly M Leach; Karen F Vieira; Sung-Hae Lee Kang; Ara Aslanian; Martin Teichmann; Robert G Roeder; Jörg Bungert
Journal:  Nucleic Acids Res       Date:  2003-02-15       Impact factor: 16.971

3.  An embryonic/fetal beta-type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer.

Authors:  Osamu Tanabe; Fumiki Katsuoka; Andrew D Campbell; Weimin Song; Masayuki Yamamoto; Keiji Tanimoto; James Douglas Engel
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

4.  Cooperative activities of hematopoietic regulators recruit RNA polymerase II to a tissue-specific chromatin domain.

Authors:  Kirby D Johnson; Jeffrey A Grass; Meghan E Boyer; Carol M Kiekhaefer; Gerd A Blobel; Mitchell J Weiss; Emery H Bresnick
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-22       Impact factor: 11.205

5.  Formation of a tissue-specific histone acetylation pattern by the hematopoietic transcription factor GATA-1.

Authors:  Danielle L Letting; Carrie Rakowski; Mitchell J Weiss; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

6.  USF and NF-E2 cooperate to regulate the recruitment and activity of RNA polymerase II in the beta-globin gene locus.

Authors:  Zhuo Zhou; Xingguo Li; Changwang Deng; Paul A Ney; Suming Huang; Jörg Bungert
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

Review 7.  Regulation and function of the NFE2 transcription factor in hematopoietic and non-hematopoietic cells.

Authors:  Jadwiga J Gasiorek; Volker Blank
Journal:  Cell Mol Life Sci       Date:  2015-02-27       Impact factor: 9.261

Review 8.  Important roles of reversible acetylation in the function of hematopoietic transcription factors.

Authors:  Xiaofang Huo; Junwu Zhang
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

9.  Lineage-specific activators affect beta-globin locus chromatin in multipotent hematopoietic progenitors.

Authors:  Stefania Bottardi; Julie Ross; Natacha Pierre-Charles; Volker Blank; Eric Milot
Journal:  EMBO J       Date:  2006-07-13       Impact factor: 11.598

10.  MafG sumoylation is required for active transcriptional repression.

Authors:  Hozumi Motohashi; Fumiki Katsuoka; Chika Miyoshi; Yasuhiro Uchimura; Hisato Saitoh; Claire Francastel; James Douglas Engel; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.